Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
2249 studies found for:    cancer pain
Show Display Options
Rank Status Study
1 Active, not recruiting Real-time Cancer Pain Assessment and Intervention
Conditions: Malignancy;   Cancer Pain
Interventions: Procedure: real-time monitoring and instruction of cancer pain;   Procedure: standard cancer pain care
2 Completed
Has Results
An Efficacy and Safety Study of Hydromorphone Oral Osmotic System (OROS) in Korean Participants With Cancer Pain
Condition: Cancer Pain
Intervention: Drug: Hydromorphone
3 Not yet recruiting Exploring New Technologies to Manage Cancer Pain in the Community
Conditions: Neoplasms;   Pain
Intervention: Other: Qualitative interviews
4 Recruiting Prospective Longitudinal Observational Study to Evaluate the Clinical Characteristics and Opioids Treatments in Patients With Breakthrough Cancer Pain
Conditions: Tumor;   Cancer Pain;   Breakthrough Cancer Pain;   Neuropathic Pain
Interventions: Drug: Morphine;   Drug: Fentanyl;   Drug: Methadone;   Drug: Buprenorphine;   Drug: Oxycodone;   Drug: Hydromorphone;   Drug: Tapentadol
5 Terminated
Has Results
Study of Breakthrough Cancer Pain: Assessment of Fentanyl Buccal Tablets Titration and Treatment in Opioid-Tolerant Patients
Conditions: Cancer Pain;   Breakthrough Pain
Intervention: Drug: Fentanyl Buccal Tablet (FBT)
6 Terminated
Has Results
Lenalidomide (Revlimid) for the Treatment of Refractory Cancer Pain
Conditions: Advanced Cancer;   Pain
Intervention: Drug: Lenalidomide
7 Completed The Effect of Cancer Pain Management Protocol on Hospitalized Cancer Patients: A Pilot Study
Condition: Cancers, Pain
Intervention: Drug: Cancer pain management
8 Completed Study to Evaluate Effectiveness and Tolerability of OROS Hydromorphone for Cancer Pain Treatment in Korean Patients
Condition: Cancer Pain
Intervention: Drug: OROS hydromorphone
9 Active, not recruiting Improving Cancer Pain Management Through Self-Care
Conditions: Cancer;   Pain
Intervention: Behavioral: PRO-SELF PLUS Pain Management Program
10 Completed Case-control Study- Cancer Pain: Uncontrolled Pain as Depression Development Predictor in Oncologic Patients (Fentanyl)
Condition: Cancer Pain
Intervention: Other: Visual analogue scales (EVAs)
11 Terminated Marijuana for Cancer Pain
Condition: Neoplasms
Intervention: Drug: Smoked Marijuana
12 Completed Immediate-Release Oxycodone Capsules Study in Cancer Pain
Condition: Cancer
Interventions: Drug: Oxycodone;   Drug: Morphine
13 Completed Morphine as First Drug for Cancer Pain
Condition: Chronic Pain
Intervention: Drug: Opioid
14 Terminated A Clinical Trial to Assess the Clinical Benefit of SSR411298 as Adjunctive Treatment for Persistent Cancer Pain
Conditions: Pain;   Breakthrough Cancer Pain
Interventions: Drug: SSR411298;   Drug: Placebo (for SSR411298)
15 Active, not recruiting Observational Registry Study of Quality of Life When Treating BTcP With Abstral
Conditions: Quality of Life;   Breakthrough Cancer Pain
Intervention: Drug: Fentanyl
16 Completed The Effectiveness of a Patient Self-reported Pain Scoring Tool and a Satisfaction Survey on Cancer Pain Management
Condition: Pain
Intervention: Behavioral: No intervention
17 Completed A Observational Study of Assessment and Treatment Adequacy of Emergency Cancer Pain in Tertiary Cancer Hospital
Condition: TO STUDY EMERGENCY CANCER PAIN PATTERNS AND TREATMENT ADEQUACY.
Intervention:
18 Not yet recruiting Study of Opioid Rotation Versus Opioid Escalation in Patients With Moderate to Severe Cancer Pain
Conditions: Cancer;   Pain
Interventions: Drug: oral oxycodone;   Drug: oral hydromorphone;   Drug: fentanyl patch
19 Terminated
Has Results
A Study to Compare Safety and Efficacy of Osmotic Release Oral Syytem (OROS) Hydromorphone Hydrochloride (HCl) With Morphine Sustain Release (SR) in Participants With Cancer Pain
Condition: Cancer Pain
Interventions: Drug: Hydromprphone Hydrochloride (HCl) OROS;   Drug: Morphine Sustain Release (SR)
20 Completed Efficacy & Safety Study of Nasalfent (Fentanyl Citrate Nasal Spray) for Treatment of Breakthrough Cancer Pain in Patients Taking Regular Opioids
Condition: Cancer Pain
Intervention: Drug: Fentanyl (Nasalfent, Fentanyl Citrate Nasal Spray)

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years